— Research Library
Literature reviews on longevity, metabolic health, growth hormone axis, and regenerative compounds. For research use only.
— Featured overview
Most research peptides have never been near a regulatory filing. Sermorelin was an approved drug in the 1980s — and that history is exactly why
— All research posts
Most anxiety compounds calm the brain by broadly slowing it down. Selank appears to work differently. Published research suggests it reduces anxiety-like behavior without the
Semax started as a stroke treatment. Then researchers noticed something else: it appeared to sharpen cognition in healthy subjects too. Over three decades of study
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is one of the longest-studied peptide compounds in biological research, with a published literature spanning more than five decades. First isolated
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that occupies a distinct position in the peptide research literature. Unlike most compounds studied solely
PT-141, also known by its pharmaceutical name bremelanotide, is a synthetic peptide that acts as an agonist at melanocortin receptors — a family of G-protein
BPC-157 and TB-500 are among the most studied synthetic peptides in preclinical tissue repair research. While each has a substantial independent literature, researchers have increasingly
BPC-157 (Body Protection Compound 157) represents one of the most extensively researched synthetic peptides in preclinical literature, with over 500 peer-reviewed studies indexed on PubMed
